Clinical Trial Update: "Answers in Hours" A Randomized Controlled Trial Using Microbiome Metagenomics for Bile Duct Cultures [NA]

View source ↗

Summary

Mayo Clinic-conducted randomized controlled trial evaluating microbiome metagenomics for bile duct cultures in patients with benign and malignant pancreatic neo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Pancreatic Neoplasm
• Malignant Pancreatic Neoplasm

Snippet

Sponsor: Mayo Clinic | Conditions: Benign Pancreatic Neoplasm, Malignant Pancreatic Neoplasm | NA | Status: TERMINATED | Results posted: 2025-02-18